Literature DB >> 1800709

Multiple-dose acetaminophen pharmacokinetics.

C G Sahajwalla1, J W Ayres.   

Abstract

Four different treatments of acetaminophen (Tylenol) were administered in multiple doses to eight healthy volunteers. Each treatment (325, 650, 825, and 1000 mg) was administered five times at 6-h intervals. Saliva acetaminophen concentration versus time profiles were determined. Noncompartmental pharmacokinetic parameters were calculated and compared to determine whether acetaminophen exhibited linear or dose-dependent pharmacokinetics. For doses less than or equal to 18 mg/kg, area under the curve (AUC), half-life (t1/2), mean residence time (MRT), and ratio of AUC to dose for the first dose were compared with the last dose. No statistically significant differences were observed in dose-corrected AUC for the first or last dose among subjects or treatments. Half-lives and MRT were not significantly different among treatments for the first or the last dose. Statistically significant differences in t1/2 and MRT were noted (p less than 0.05) among subjects for the last dose. A plot of AUC versus dose for the first and the last doses exhibited a linear relationship. Dose-corrected saliva concentration versus time curves for the treatments were superimposable. Thus, acetaminophen exhibits linear pharmacokinetics for doses of 18 mg/kg or less. Plots of AUC versus dose for one subject who received doses higher than 18 mg/kg were curved, suggesting nonlinear behavior of acetaminophen in this subject.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1800709     DOI: 10.1002/jps.2600800911

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

Review 1.  Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment.

Authors:  Andrew J McLachlan; Sally Bath; Vasi Naganathan; Sarah N Hilmer; David G Le Couteur; Stephen J Gibson; Fiona M Blyth
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

2.  Physiologically based modeling of the pharmacokinetics of acetaminophen and its major metabolites in humans using a Bayesian population approach.

Authors:  Todd J Zurlinden; Brad Reisfeld
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-01-31       Impact factor: 2.441

3.  Effects of imatinib mesylate on the pharmacokinetics of paracetamol (acetaminophen) in Korean patients with chronic myelogenous leukaemia.

Authors:  Dong-Wook Kim; Eugene Y Tan; Yu Jin; Sahee Park; Michael Hayes; Eren Demirhan; Horst Schran; Yanfeng Wang
Journal:  Br J Clin Pharmacol       Date:  2011-02       Impact factor: 4.335

4.  Successful Use of [14C]Paracetamol Microdosing to Elucidate Developmental Changes in Drug Metabolism.

Authors:  Miriam G Mooij; Esther van Duijn; Catherijne A J Knibbe; Karel Allegaert; Albert D Windhorst; Joost van Rosmalen; N Harry Hendrikse; Dick Tibboel; Wouter H J Vaes; Saskia N de Wildt
Journal:  Clin Pharmacokinet       Date:  2017-10       Impact factor: 6.447

5.  Multiscale modeling reveals inhibitory and stimulatory effects of caffeine on acetaminophen-induced toxicity in humans.

Authors:  C Thiel; H Cordes; V Baier; L M Blank; L Kuepfer
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-01-28

6.  Selection of 12-Hour Sustained-Release Acetaminophen (Paracetamol) Formulation Through Comparison of Pharmacokinetic Profiles of 4 Sustained-Release Prototype Formulations and Standard Acetaminophen Formulation: An Open-Label, Randomized, Proof-of-Principle Pharmacokinetic Study.

Authors:  Yong Yue; Dongzhou J Liu
Journal:  Clin Pharmacol Drug Dev       Date:  2017-08-16

7.  Bioequivalence and Safety of Twice-Daily Sustained-Release Paracetamol (Acetaminophen) Compared With 3- and 4-Times-Daily Paracetamol: A Repeat-Dose, Crossover Pharmacokinetic Study in Healthy Volunteers.

Authors:  Dongzhou J Liu; Agron Collaku
Journal:  Clin Pharmacol Drug Dev       Date:  2017-08-16

8.  Clinical Evaluation of Acetaminophen-Galgeuntang Interaction Based on Population Approaches.

Authors:  Quyen Thi Tran; So Jung Park; Hyun-Moon Back; Lien Thi Ngo; Duc Tuan Cao; Hung Van Nguyen; Sangkeun Jung; Jung-Woo Chae; Yang Chun Park; Hwi-Yeol Yun
Journal:  Pharmaceutics       Date:  2020-12-04       Impact factor: 6.321

9.  Pharmacokinetic properties of intramuscular versus oral syrup paracetamol in Plasmodium falciparum malaria.

Authors:  Thanaporn Wattanakul; Pramote Teerapong; Katherine Plewes; Paul N Newton; Wirongrong Chierakul; Kamolrat Silamut; Kesinee Chotivanich; Ronnatrai Ruengweerayut; Nicholas J White; Arjen M Dondorp; Joel Tarning
Journal:  Malar J       Date:  2016-04-27       Impact factor: 2.979

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.